Effects of thymectomy and tolerance induction on tumor immunity in adult Xenopus laevis
โ Scribed by Jacques Robert; Chantal Guiet; Nicholas Cohen; Louis Du Pasquier
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- French
- Weight
- 58 KB
- Volume
- 70
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
Major-histocompatibility-complex homozygous partially inbred adults of the ff strain of Xenopus reject transplants of tumor cells of ff strain origin; ff tadpoles do not. Thymectomy, performed 5 days after fertilization, abrogated the adult tumor-rejection response suggesting that in this system tumor rejection is immunologically mediated by T cells. Thymectomy later in larval life did not alter tumor rejection, but it did reduce T-cell numbers. Tolerance to minorhistocompatibility(H) antigens segregating within the ff family, which was induced by grafting adult skin to metamorphosing larvae, did not affect the tumor-rejection capacity of the tolerant adult hosts. This suggests that the ff-2 tumor expresses (a) tumor-specific antigen(s). Immunization of larvae with tumor cells did not induce tolerance to skin grafts transplanted during adult life. Indeed, such grafts were rejected in accelerated fashion, suggesting that memory cells generated in the larvae persist through metamorphosis.
๐ SIMILAR VOLUMES
Indomethacin, an inhibitor of cyclo-oxygenase given orally, reduced the tumorigenicity of cancer cells in a non-immunogenic murine model of mammary adenocarcinoma (4T1). In the presence of indomethacin, a dose-dependent immune protection could be induced most effectively by immunizing mice with 1 to
B7-1 (CD80) co-stimulatory molecule gene-transduced Lewis lung carcinoma (LLC) cells (LLC/B7 cells) resulted in remarkable loss of tumorigenicity in syngeneic C57BL/6 mice (87.5% rejection) compared to B7-negative, wild-type LLC (LLC/wt) cells (0% rejection). However, mice that had rejected LLC/B7 c
Although tumor-specific T lymphocytes recognize tumorassociated antigens (TAA) present on their cell surface via major histocompatibility complex (MHC) molecules, T cells require other activating signals. These are provided by costimulatory molecules, including B7-1 (CD80), B7-2 (CD86) and intercell